Reporting owner

Hyep Ivan

Reporting owner CIK 0002034668 · Chief Financial Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Hyep IvanHyep IvanHyep Ivan · December 22, 2025 · Exercise / conversion · Common StockHyep Ivan · November 24, 2025 · Exercise / conversion · Common StockHyep Ivan · November 21, 2025 · Exercise / conversion · Common StockNov 21, 2025Dec 22, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 22, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion
Nov 21, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Bicara Therapeutics Inc.BCAX · company listings
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M9,2003.7898Value: 34,866.16Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M17,7953.7898Value: 67,439.491Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M6053.7898Value: 2,292.829Currency not specifiedView ↗